Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MGTX
MEIRAGTX HOLDINGS PLC
NASDAQ
$13.82
▼ DOWN 2.26% (-0.32)

KEY STATISTICS

Market Cap$1.28 B
52w High$15.35
52w Low$6.62
Dividend Yield—
Frequency—
P/E-9.34
Volume914.21K
Shares Out.92.61M

COMPANY

LEADERSHIP

Alexandria Forbes
CHIEF EXECUTIVE
Alexandria Forbes

COMPENSATION 2026

Salary$840,000
Stock Awards$5,823,500
Incentive Plan Pay$0
All Other Comp.$21,000
Total$8,330,006

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 8, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
393

PRICE TARGET

Target High$26.00
Target Low$26.00
Target Median$26.00
Target Consensus$26.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$7.07M
NOV
12
THU

PRICE

$13.82 ▼ DOWN 2.26% (−$0.32)
$13.65$13.80$13.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM13.82

About MeiraGTx Holdings plc

https://www.meiragtx.com ↗

MeiraGTx Holdings plc is a clinical-stage gene therapy company developing treatments for serious diseases, including ocular, neurodegenerative, and radiation-induced conditions, with ongoing programs in multiple phases and collaborations like Jans...

INDUSTRY

Biotechnology

A PRODUCT MEIRAGTX HOLDINGS PLC IS KNOWN FOR

AAV-GAD
AAV-GAD

AAV-GAD is an investigational gene therapy for Parkinson's disease, receiving FDA RMAT designation and featuring a major collaboration for development and commercialization.

COMPETITORS

COMPETITOR
QURE COMPARE
RGNX COMPARE
SLDB COMPARE
SRPT COMPARE
VYGR COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Related Party Service Revenue$410K $2.3M ▲$293K ▼$104.91M ▲
Service— — — $11.88M

ETFS HOLDING THIS STOCK

ETFS HOLDING
84
LISTED HERE
21
RANKED BY POSITION SIZE
XSU.TO
0.03% · 1.5M
JSML
1.69% · 437.3K
VTWO
0.02% · 337.3K
KOMP
0.13% · 258.1K
SBIO
0.65% · 113.8K
PSC
0.04% · 75.8K
PRFZ
0.03% · 56.9K
XRSG.L
0.03% · 55.0K
BBC
0.88% · 32.7K
RSSL
0.03% · 28.5K
FHLC
0.01% · 26.6K
GSSC
0.03% · 21.7K
ACSG
0.11% · 4.2K
ESSC
0.12% · 3.8K
BIB
0.05% · 3.3K
PQ
PQSG
0.20% · 1.9K
AESG
1.16% · 1.6K
AVUQ
0.00% · 285
USFMDN.MX
0.00% · 248
FVI
0.01% · 233
RESM
0.03% · 136

INSTITUTIONAL OWNERSHIP

SHARES OWNED
74.37%
HOLDERS
203
TOP 12 OF 203 · RANKED BY POSITION SIZE
Perceptive Advisors LLC
12.6M sh · $103.79M
Sanofi
12.2M sh · $164.79M
Rubric Capital Management LP
9.1M sh · $122.94M
Johnson & Johnson
6.6M sh · $89.72M
Blackrock, Inc.
4.8M sh · $64.27M
Adage Capital Partners Gp, L.L.C.
4.4M sh · $59.44M
Prosight Management, LP
4.1M sh · $33.66M
Opaleye Management Inc.
3.5M sh · $47.96M
Millennium Management LLC
3.5M sh · $30.01M
Johnson & Johnson Innovation - Jjdc, Inc.
2.9M sh · $44.93M
683 Capital Management, LLC
2.6M sh · $21.6M
Blackrock Inc.
2.5M sh · $10.62M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings2
Price To Book1
Overall Score3

INSIDER TRADES

★
DIRECTOR, OFFICER: PRESIDENT & CEO
Forbes Alexandria
Sale · 62.0K shares
2026-08-18
★
OFFICER: CFO & COO
Giroux Richard
Sale · 56.0K shares
2026-07-21
★
OFFICER: CHIEF SCI OFCR, OPHTHALMOLOGY
Naylor Stuart
Sale · 2.5K shares
2026-07-07
★
OFFICER: CHIEF SCI OFCR, OPHTHALMOLOGY
Naylor Stuart
Sale · 25.1K shares
2026-07-07

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OUTPERFORM 2
OVERWEIGHT 1
6 GRADES IN THE LAST 12 MONTHS
RBC Capital OUTPERFORM HC Wainwright & Co. BUY Piper Sandler OVERWEIGHT Evercore ISI Group OUTPERFORM B of A Securities BUY Chardan Capital BUY

SECTORS PEERS

PEERPRICE
ERAS$18.03COMPARE
IOVA$8.01COMPARE
MBX$63.00COMPARE
ABSI$8.71COMPARE
AVBP$30.17COMPARE
REPL$15.50COMPARE
MLTX$14.99COMPARE
ARVN$9.18COMPARE